← Open Payments lookup

KRISTI LEBESCO: Open Payments

NPI 1386279172 · DANA POINT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,615 in 142 payments from 18 companies in 2025. Trend: 2023 $1,172 · 2024 $1,232 · 2025 $2,615

Food & beverage: $2,615
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.25$377
Alkermes, Inc.16$269
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$256
E.R. Squibb & Sons, L.L.C.12$252
Vanda Pharmaceuticals Inc.12$218
ABBVIE INC.12$206
Axsome Therapeutics, Inc.8$196
Neurocrine BioSciences, Inc.12$165
Teva Pharmaceuticals USA, Inc.7$150
Supernus Pharmaceuticals, Inc.7$138

Products named: REXULTI, ARISTADA, CAPLYTA, COBENFY, VRAYLAR, Auvelity, INGREZZA, FANAPT.

Industry payments across CA — which companies pay providers there.